论文部分内容阅读
目的评价核苷酸类似物阿德福韦酯治疗乙肝的疗效。方法将慢性乙肝初治患者70例,分为对照组与治疗组,分别使用干扰素IFNa-2b与核苷酸类似物阿德福韦酯治疗,比较两组的疗效及治疗成本。结果治疗组6个月时的丙氨酸转氨酶(ALT)复常率为85.7%显著高于对照组的34.3%(P<0.05),HBeAg转阴率为31.4%与对照组的28.6%比较无统计学意义(P>0.05)。结论核苷酸类似物阿德福韦酯治疗乙肝疗效好,不良反应少,患者经济负担小,值得临床推广。
Objective To evaluate the efficacy of nucleotide analog adefovir dipivoxil in the treatment of hepatitis B. Methods 70 patients with chronic hepatitis B were divided into control group and treatment group. Interferon-IFN-2b and nucleotide analogue adefovir dipivoxil were used respectively to compare the curative effect and treatment cost of the two groups. Results The normalization rate of alanine aminotransferase (ALT) at 6 months in treatment group was significantly higher than that in control group (85.7% vs 34.3%, P <0.05), HBeAg negative rate was 31.4%, compared with 28.6% in control group Statistical significance (P> 0.05). Conclusion The nucleotide analog adefovir dipivoxil treatment of hepatitis B efficacy, fewer adverse reactions, patients with small economic burden, it is worth clinical promotion.